Therapeutic New Era for Atopic Dermatitis: Part 1. Biologics

Atopic dermatitis (AD) is a chronic, inflammatory cutaneous disease driven by immune dysregulation and skin barrier dysfunction. We are currently experiencing a new era of understanding of the pathogenesis of AD and, as a consequence, a new era of innovation in therapeutics, including small molecule...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Jiyoung, Choi, Yusung, Simpson, Eric Lawrence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875213/
https://www.ncbi.nlm.nih.gov/pubmed/33911806
http://dx.doi.org/10.5021/ad.2021.33.1.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875213/
https://www.ncbi.nlm.nih.gov/pubmed/33911806
http://dx.doi.org/10.5021/ad.2021.33.1.1

Ejemplares similares